Metraipolis › archive › dc_f080358bd75f

Integrated Genomic, Transcriptomic, and Circulating Biomarkers Predict Benefit to Immune Checkpoint Inhibitor Plus Chemotherapy in Advanced Non-Small Cell… — Europe PMC PMID:42415854

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42415854
DOI: 10.1002/mco2.70846
License (as archived): solo-consultazione
Archived: 2026-10-18T10:56:56.957Z
SHA-256 of the archived text: f0ad422859ae74b6f097f92e4950ee3c79694c61e1d74ccfb7e6185e22a20d77
Stable URL of this page: https://metraipolis.com/documento/dc_f080358bd75f

How to cite

Integrated Genomic, Transcriptomic, and Circulating Biomarkers Predict Benefit to Immune Checkpoint Inhibitor Plus Chemotherapy in Advanced Non-Small Cell… — Europe PMC PMID:42415854 — Europe PMC (en), https://europepmc.org/article/MED/42415854 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f080358bd75f (Metraipolis archive dc_f080358bd75f, sha256 f0ad422859ae74b6f097f92e4950ee3c79694c61e1d74ccfb7e6185e22a20d77)

BibTeX

@misc{dcf080358bd75f,
  title = {Integrated Genomic, Transcriptomic, and Circulating Biomarkers Predict Benefit to Immune Checkpoint Inhibitor Plus Chemotherapy in Advanced Non-Small Cell… — Europe PMC PMID:42415854},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42415854},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f080358bd75f; sha256 f0ad422859ae74b6f097f92e4950ee3c79694c61e1d74ccfb7e6185e22a20d77},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42415854. Agents can read the archived copy with the MCP tool read_document.